These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16210374)

  • 1. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples.
    Wu Y; Liu Z; Xiang Z; Zeng C; Chen Z; Ma X; Li L
    Endocrinology; 2006 Jan; 147(1):44-50. PubMed ID: 16210374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-related glomerulopathy: an emerging epidemic.
    Kambham N; Markowitz GS; Valeri AM; Lin J; D'Agati VD
    Kidney Int; 2001 Apr; 59(4):1498-509. PubMed ID: 11260414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy.
    He J; Yuan G; Cheng F; Zhang J; Guo X
    Metab Syndr Relat Disord; 2017 Sep; 15(7):344-353. PubMed ID: 28737448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.
    McPherson KC; Shields CA; Poudel B; Johnson AC; Taylor L; Stubbs C; Nichols A; Cornelius DC; Garrett MR; Williams JM
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F911-F921. PubMed ID: 32068459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy.
    Tsuboi N; Utsunomiya Y; Kanzaki G; Koike K; Ikegami M; Kawamura T; Hosoya T
    Clin J Am Soc Nephrol; 2012 May; 7(5):735-41. PubMed ID: 22403274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-related glomerulopathy in China: a case series of 90 patients.
    Chen HM; Li SJ; Chen HP; Wang QW; Li LS; Liu ZH
    Am J Kidney Dis; 2008 Jul; 52(1):58-65. PubMed ID: 18423814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the use of glomerulomegaly as a surrogate marker of glomerular damage and for alpha-linolenic acid-rich oils in the treatment of early obesity-related glomerulopathy in a diet-induced rodent model of obesity.
    Caligiuri SP; Blydt-Hansen T; Love K; Grégoire M; Taylor CG; Zahradka P; Aukema HM
    Appl Physiol Nutr Metab; 2014 Aug; 39(8):951-9. PubMed ID: 24927777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of gene expression of vascular endothelial growth factor and flk-1 in the renal glomeruli of the normal rat kidney using the laser microdissection system.
    Inoue K; Sakurada Y; Murakami M; Shirota M; Shirota K
    Virchows Arch; 2003 Feb; 442(2):159-62. PubMed ID: 12596067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of metabolic risk marker in obesity-related glomerulopathy.
    Chen HM; Chen Y; Zhang YD; Zhang PP; Chen HP; Wang QW; Li LS; Liu ZH
    J Ren Nutr; 2011 Jul; 21(4):309-15. PubMed ID: 20833076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
    Khan S; Shukla S; Sinha S; Meeran SM
    Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of Connexin43 expression in a rat model of obesity-related glomerulopathy.
    Zhao Y; Li G; Wang Y; Liu Z
    Exp Mol Pathol; 2018 Feb; 104(1):12-18. PubMed ID: 29246788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of tumor necrosis factor-alpha induces the overproduction of postprandial intestinal apolipoprotein B48-containing very low-density lipoprotein particles: evidence for related gene expression of inflammatory, insulin and lipoprotein signaling in enterocytes.
    Qin B; Dawson H; Anderson RA
    Exp Biol Med (Maywood); 2010 Feb; 235(2):199-205. PubMed ID: 20404035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between body fat distribution and renal damage in Chinese with obesity.
    Chen H; Liu Z; Li S; Chen Y; Yang B; Cai J; Wang Q; Li L
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):99-103. PubMed ID: 18095240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs.
    Gayet C; Leray V; Saito M; Siliart B; Nguyen P
    Br J Nutr; 2007 Sep; 98(3):497-503. PubMed ID: 17475082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP; Federspiel C; Helderman H; Fogo AB
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.